Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle ...

Abbott trades at a fraction of Glaukos' valuation, but one company burns cash while the other generates billions.

Abbott Laboratories (ABT) is back in focus after reporting Q1 2026 sales of US$11.16b with solid contributions from Medical ...

July 20 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Thursday beat quarterly profit expectations as a rebound in surgical procedure volumes drove demand for medical devices despite high ...

Abbott's broad healthcare reach and Intuitive's robotic surgery focus present distinct financial strengths and risks for ...

Oct 19 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Wednesday reported lower-than-expected growth in international medical device sales, hit by a strong dollar and supply challenges in ...